Nanoparticle Vaccine Triggers Interferon-Gamma Production and Confers Protective Immunity against Porcine Reproductive and Respiratory Syndrome Virus
Yangyang Sun,
No information about this author
Yanni Gao,
No information about this author
Tongjian Su
No information about this author
et al.
ACS Nano,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 6, 2025
The
swine
industry
annually
suffers
significant
economic
losses
caused
by
porcine
reproductive
and
respiratory
syndrome
virus
(PRRSV).
Because
the
available
commercial
vaccines
have
limited
protective
efficacy
against
epidemic
PRRSV,
there
is
an
urgent
need
for
innovative
solutions.
Nanoparticle
induce
robust
immune
responses
become
a
promising
direction
in
vaccine
development.
In
this
study,
we
designed
produced
self-assembling
nanoparticle
derived
from
thermophilic
archaeal
ferritin
to
combat
PRRSV.
First,
multiple
T
cell
epitopes
targeting
viral
structural
proteins
were
identified
IFN-γ
screening
after
PRRSV
infection.
Three
different
self-assembled
nanoparticles
with
GP3,
GP4,
GP5
constructed
mixed
generate
FeCocktail
vaccine.
Experiments
showed
that
effectively
activated
CD4+
CD8+
cells
effector
memory
mice.
Piglets
immunized
generated
specific
antibodies
exhibited
increased
levels
of
PRRSV-specific
functional
cells.
also
provided
challenge,
including
mitigation
clinical
symptoms,
reduction
loads
serum
lungs,
alleviation
lung
tissue
damage.
conclusion,
study
offers
candidate
combating
affirms
utility
protein
as
platform
next-generation
Language: Английский
Strategies for engineering biomimetic materials for tumor therapy
Zhaoyu Ma,
No information about this author
Kai Zhang,
No information about this author
Yanli Zhao
No information about this author
et al.
Matter,
Journal Year:
2025,
Volume and Issue:
8(1), P. 101899 - 101899
Published: Jan. 1, 2025
Language: Английский
Regulation of ferroptosis by nanotechnology for enhanced cancer immunotherapy
Haohan Zhou,
No information about this author
Yiyun Cheng,
No information about this author
Quan Huang
No information about this author
et al.
Expert Opinion on Drug Delivery,
Journal Year:
2024,
Volume and Issue:
21(6), P. 921 - 943
Published: June 2, 2024
Introduction
This
review
explores
the
innovative
intersection
of
ferroptosis,
a
form
iron-dependent
cell
death,
with
cancer
immunotherapy.
Traditional
treatments
face
limitations
in
efficacy
and
specificity.
Ferroptosis
as
new
paradigm
biology,
targets
metabolic
peculiarities
cells
may
potentially
overcome
such
limitations,
enhancing
Language: Английский
Induced Ferroptosis Pathway by Regulating Cellular Lipid Peroxidation With Peroxynitrite Generator for Reversing “Cold” Tumors
Ruipeng Li,
No information about this author
Haitao Yuan,
No information about this author
Chuangxin Zhang
No information about this author
et al.
Small,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 16, 2024
Abstract
Overcoming
the
resistance
of
tumor
cells
to
apoptosis
and
immunosuppression
is
an
important
challenge
improve
immunotherapy.
Non‐apoptotic
death
mode
ferroptosis
has
been
regarded
as
a
new
strategy
enhance
immunotherapy
against
drug‐resistant
cancers.
The
lethal
accumulation
lipid
peroxides
(LPO)
determines
progress
ferroptosis.
high
susceptibleness
provides
opportunity
for
combating
triple‐negative
breast
cancer.
Reactive
nitrogen
species
(RNS)
produced
by
nitric
oxide
(NO)
reactive
oxygen
(ROS)
more
than
ROS
cells.
Herein,
RNS‐mediated
inducing
pathway
proposed
improving
LPO
accumulation,
constructed
multifunctional
liposome
(Lipo‐MT‐SNAP)
comprised
peroxynitrite
(ONOO
−
)
generator,
targeted
group,
inhibiting
glutathione
peroxidase
4
(GPX4),
basic
units
(dipalmitoyl
phosphatidylcholine
cholesterol).
significant
enhancement
resulted
from
intense
oxidative
damage
ONOO
impaired
synthesis
GPX4
depleting
glutathione,
which
further
amplified
triggered
immunogenic
cell
death.
In
vivo,
photoimmunotherapy
can
promote
polarization
M2
M1
macrophages
dendritic
maturation,
infiltrate
T
cells,
regulate
secretion
inflammatory
factors,
reprogram
microenvironment.
powerful
induces
strong
immunogenicity
effectively
inhibit
proliferation.
Language: Английский
Current progress in the regulation of endogenous molecules for enhanced chemodynamic therapy
Chemical Science,
Journal Year:
2024,
Volume and Issue:
15(26), P. 9915 - 9926
Published: Jan. 1, 2024
A
comprehensive
summary
of
how
different
endogenous
molecules'
metabolic
processes
(including
H
2
O
,
iron,
lactate,
GSH,
and
lipid
metabolisms)
impact
Fenton
chemistry
is
provided
in
this
perspective
for
advancing
chemodynamic
therapy
against
cancer.
Language: Английский
Ferrocene-Conjugated Paclitaxel Prodrug for Combined Chemo-Ferroptosis Therapy of Cancer
Shaojin Lu,
No information about this author
Dengyuan Hao,
No information about this author
Qian Meng
No information about this author
et al.
ACS Applied Materials & Interfaces,
Journal Year:
2024,
Volume and Issue:
16(36), P. 47325 - 47336
Published: Aug. 27, 2024
Herein,
we
developed
a
paclitaxel
prodrug
(PSFc)
through
the
conjugation
of
(PTX)
and
ferrocene
Language: Английский
Hijacking the hyaluronan assisted iron endocytosis to promote the ferroptosis in anticancer photodynamic therapy
Carbohydrate Polymers,
Journal Year:
2024,
Volume and Issue:
351, P. 123123 - 123123
Published: Dec. 6, 2024
Language: Английский
Controlled Synthesis of the FeB Nanometallic Glasses with Stronger Electron Donating Capability to Activate Molecular Oxygen for the Enhanced Ferroptosis Therapy
Guanjie Shi,
No information about this author
Yongxuan Zhang,
No information about this author
Wenting Wang
No information about this author
et al.
Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 8, 2024
Abstract
Considering
the
strong
electron‐donating
ability
and
superior
biocompatibility,
integration
of
zero‐valent
iron
nanostructure
Fe
0
(electron‐reservoir)
boron
B
offers
great
promise
for
fabricating
novel
ferroptosis
nanoagents.
Nevertheless,
controlled
facile
synthesis
alloyed
nanostructure‐FeB
nanometallic
glasses
(NMGs)
has
remained
a
long‐standing
challenge.
Herein,
complexion‐reduction
strategy
is
proposed
FeB
NMGs
with
greater
electron
donating
capacity
to
activate
molecular
oxygen
improved
therapy.
In‐depth
mechanism
reveales
that
effectively
prevent
long‐range
diffusion
,
resulting
in
amorphous
nanoparticles
(FeB
NPs).
The
NPs
display
stronger
capability
transfer
rate
9.4
times
higher
than
NPs,
which
produce
∙O
2
−
H
O
∙OH.
vitro
cellular
experiments
confirm
FeB‐ss‐SiO₂
(encapsulation
SiO
outlayer
containing
‐S‐S‐
bonds)
demonstrates
enhanced
ferroptosis.
tumor‐bearing
mice
models
shows
exhibited
biocompatibility
tumor
inhibition
effect
(inhibition
73%),
improve
overall
survival
30
days
post‐treatment.
This
study
will
provide
an
innovative
way
design
therapeutic
nanoagents
cancer
treatments.
Language: Английский